A clinical trial of aminoglutethimide in advanced postmenopausal breast carcinoma: Low response in patients previously treated with medroxyprogesterone
- 15 April 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (4) , 423-428
- https://doi.org/10.1016/0277-5379(85)90031-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Aminoglutethimide as Treatment of Postmenopausal Women with Advanced Breast CarcinomaAnnals of Internal Medicine, 1982
- Glucocorticoid-Like Actions of Medroxyprogesterone Acetate upon MtTW15 Rat Mammosomatotropic Pituitary Tumors*Endocrinology, 1981
- The influence of high doses of oral medroxyprogesterone acetate on glucose tolerance, serum insulin levels and adrenal response to ACTHArchiv für Gynäkologie, 1980
- AMINOGLUTETHIMIDE IN TREATMENT OF METASTATIC BREAST CARCINOMAThe Lancet, 1978
- The Effect of Medroxyprogesterone Acetate on the Pituitary-Adrenal AxisJournal of Clinical Endocrinology & Metabolism, 1976
- Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic TrialJournal of Clinical Endocrinology & Metabolism, 1967
- Data on the mechanism of adrenal suppression by medroxyprogesteroneSteroids, 1965
- THE CORTISONE-LIKE EFFECT OF 6α=METHYL-17α-ACETOXYPROGESTERONE IN THE ADRENALECTOMIZED MANActa Endocrinologica, 1963